// App-Quantinova.ai

BSH19‐PO‐009 : The clinical validation and laboratory implementation of fragment analysis for the measurement of the FLT3‐ITD allelic ratio in patients with Acute Myeloid Leukaemia

Researchers

Presenter

  • C. Wilton

Principal Investigators

  • B. Newman

  • E. Gudgin

  • M. Scott

  • A. Jones

Medical Centers

  • Cambridge University Hospitals, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Nucleophosmin

  • Nucleophosmin 1

  • Fms related tyrosine kinase 3

  • Apoptotic body index

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved